Armenta Bioscience ApS
Private limited companyCVR 42358444København ØActive
Armenta Bioscience ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 1.4m. Equity grew to DKK 1.3m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 1.4m to DKK 1.4m (2024 → 2025).
- Equity rose 88% (2024 → 2025), to DKK 1.3m.
Employees
- 1 fewer employees than a year earlier: 3 (07/2026) against 4 (07/2025).
Management and owners, last 24 months
- New in management: Kristoffer Tømmeraas (board member, 19/08/2026).
- Stepped down: David Valbjørn Christensen (board member, 19/08/2026).
- New owners registered: Accelerace Invest II K/S (16/04/2025).
Registrations, last 24 months
- 19/08/2026: Name changed from Gephion Bio ApS to Armenta Bioscience ApS
- 13/05/2026: Name changed from Meat Tomorrow ApS to Gephion Bio ApS
- 16/04/2025: Share capital changed from 46,040 DKK to 51,517 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2025 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −10 | 7 | 569 | −434 | −677 | −55.9% |
| Operating profit (EBIT) | −10 | 7 | −50 | −1,393 | −2,229 | −60.1% |
| Profit before tax | −10 | 7 | −50 | −1,394 | −2,229 | −59.9% |
| Net profit | −10 | 7 | −50 | −1,394 | −1,433 | −2.8% |
| Total assets | 54 | 54 | 91 | 733 | 1,398 | +90.8% |
| Equity | 30 | 36 | −14 | 684 | 1,284 | +87.6% |
| Liabilities | 24 | 18 | 105 | 49 | 114 | +134.9% |
| Cash and cash equivalents | 43 | 39 | 81 | 397 | 676 | +70.3% |
| Average number of employees | – | – | 2 | 3 | 4 | +33.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
5 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 20/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 17/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 06/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 22/05/2023 | The company | PDFXBRL |
| 2021 | 28/04/2021 – 31/12/2021 | 01/06/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,414of 69,742 Better than 2% | No. 30,305of 69,964 Better than 57% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 230of 323 Better than 29% | No. 140of 329 Better than 58% |
| Companies that are between 5 and 14 years old33,679 companies in the comparison | No. 33,005of 33,579 Better than 2% | No. 13,755of 33,678 Better than 59% |
| All companies of type ApS66,508 companies in the comparison | No. 65,352of 66,379 Better than 2% | No. 26,245of 66,505 Better than 61% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Armenta Bioscience ApS−DKK 677k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Armenta Bioscience ApS−DKK 1.4m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Armenta Bioscience ApSDKK 1.3m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Armenta Bioscience ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Kempf ApS5%
- Niklis Holdings ApS5%
- Wallbear Invest ApS25%
- Stem Cell ApS25%
- Accelerace Invest II K/S5%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Matias Heide Ankjær | Director | 28/04/2021 |
| David Valbjørn Christensen | Director | 03/03/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Mikkel Skorkjær Kongsfelt | Chair of the board | 15/07/2024 |
| Katharine Sarah Holland | Board member | 15/07/2024 |
| Kristoffer Tømmeraas | Board member | 19/08/2026 |
- Founders
- Matias Ankjær Invest ApS
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Josef Christensen | Director | 03/03/2023 | 12/02/2024 |
| David Valbjørn Christensen | Board member | 15/07/2024 | 19/08/2026 |
Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør.
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Mequ A/SManufacture of medical and dental instruments and supplies
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Armenta Bioscience ApS | Fruebjergvej 3, 2100 København Ø | 4 | 1027125987 |
Purpose
Selskabets formål er at udøve virksomhed og forskning i bæredygtige fødevarer samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
53 registered events20265 changesname 2 · management 2 · accounts 1
- NameName changed from Gephion Bio ApS to Armenta Bioscience ApS
- ManagementKristoffer Tømmeraas appointed board member
- ManagementDavid Valbjørn Christensen stepped down as board member
- AccountsAnnual report for 2025 published
- NameName changed from Meat Tomorrow ApS to Gephion Bio ApS
20254 changesaccounts 1 · capital 1 · ownership 1 · industry 1
- AccountsAnnual report for 2024 published
- CapitalShare capital changed from 46,040 DKK to 51,517 DKK
- OwnershipAccelerace Invest II K/S registered as owner (5%)
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202429 changesaddress 1 · capital 2 · management 4 · ownership 21 · accounts 1
- AddressMoved to Fruebjergvej 3, 2100 København Ø
- CapitalShare capital changed from 40,404 DKK to 46,040 DKK
- ManagementMikkel Skorkjær Kongsfelt appointed chair of the board
- ManagementKatharine Sarah Holland appointed board member
- ManagementDavid Valbjørn Christensen appointed board member
- OwnershipWallbear Invest ApS registered as owner (25%)
- OwnershipStem Cell ApS registered as owner (25%)
- OwnershipNiklis Holdings ApS registered as owner (5%)
- OwnershipKempf ApS registered as owner (5%)
- OwnershipStem Cell ApS is no longer registered as owner
- OwnershipWallbear Invest ApS is no longer registered as owner
- OwnershipKempf ApS is no longer registered as owner
- OwnershipNiklis Holdings ApS is no longer registered as owner
- OwnershipStem Cell ApS registered as owner (33.33%)
- OwnershipMATIAS ANKJÆR INVEST Aps is no longer registered as owner
- OwnershipWallbear Invest ApS registered as owner (33.33%)
- OwnershipDavid Valbjørn Christensen is no longer registered as owner
- AccountsAnnual report for 2023 published
- CapitalShare capital changed from 40,000 DKK to 40,404 DKK
- ManagementJosef Christensen stepped down as director
- OwnershipKempf ApS registered as owner (10%)
- OwnershipMATIAS ANKJÆR INVEST Aps registered as owner (33.33%)
- OwnershipDavid Valbjørn Christensen registered as owner (33.33%)
- OwnershipNiklis Holdings ApS registered as owner (10%)
- OwnershipJChristensen Invest ApS is no longer registered as owner
- OwnershipNiklis Holdings ApS is no longer registered as owner
- OwnershipKempf ApS is no longer registered as owner
- OwnershipDavid Valbjørn Christensen is no longer registered as owner
- OwnershipMATIAS ANKJÆR INVEST Aps is no longer registered as owner
20234 changesaddress 1 · accounts 1 · management 2
- AddressMoved to Centrifugevej 374, 2800 Kongens Lyngby
- AccountsAnnual report for 2022 published
- ManagementDavid Valbjørn Christensen appointed director
- ManagementJosef Christensen appointed director
20228 changesownership 6 · accounts 1 · address 1
- OwnershipNiklis Holdings ApS registered as owner (10%)
- OwnershipKempf ApS registered as owner (10%)
- OwnershipJChristensen Invest ApS registered as owner (10%)
- OwnershipDavid Valbjørn Christensen registered as owner (33.33%)
- OwnershipMATIAS ANKJÆR INVEST Aps registered as owner (33.33%)
- OwnershipMATIAS ANKJÆR INVEST Aps is no longer registered as owner
- AccountsAnnual report for 2021 published
- AddressMoved to Faste Batteri Vej 52, 2. th, 2300 København S
20213 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Meat Tomorrow ApS
- ManagementMatias Heide Ankjær appointed director
- OwnershipMATIAS ANKJÆR INVEST Aps registered as owner (100%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- RadiSurf ApSvia Mikkel Skorkjær Kongsfelt
- Dnmab ApSvia Mikkel Skorkjær Kongsfelt
- Fauna ApSvia Mikkel Skorkjær Kongsfelt
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.